Latin America

Dermatologicals is expected to see higher value growth in 2023 than in the previous year. Value growth is partly being driven by escalating prices and partly by people returning to in-person medical consultations, which lead to more recommendations…

Dermatologicals maintain a healthy growth trajectory in line with figures recorded in 2022, retaining significant value sales that surpass pre-pandemic levels. While this category typically demonstrates notable stability and does not exhibit…

Dermatologicals is set to maintain a healthy growth trajectory in current value terms in Brazil in 2023, in line with the increase recorded in 2022, driven mainly by price rises. The pandemic years were marked by a reduction in Brazilians’ purchasing…

With society operating normally once again, after the pandemic, visits to doctors in relation to skin conditions have increased. This is seeing products such as topical antifungals, vaginal antifungals, cold sore treatments, and haemorrhoid…

Retail sales of dermatologicals saw a second year of healthy growth in constant value terms in 2023. The category suffered a decline during the pandemic, when consumers spent more time at home and were therefore less exposed to environments which…

With value sales of cough and cold and allergy ( hay fever) remedies reducing to more normal levels. as concern about COVID-19 abate, there is expected to be a decline in volume sales in 2023. The exception being medicated confectionery. Along with…

Consumers have been returning to doctors’ surgeries in the post-pandemic landscape, thus hindering the sales of OTC medicines which they are instead accessing via prescription. This is noted to be the case with antihistamines, for example, along with…

In early 2023, a sixth wave of COVID-19 coincided with an upsurge in cases of the common cold and influenza, creating a "tripledemic" felt across Mexico, the US, and Central American countries, with Mexico experiencing a milder impact. This scenario…

Cough, cold and allergy (hay fever) remedies are widely consumed consumer health items in the Guatemalan market. These products have established broad distribution throughout the country, with products available throughout the modern and traditional…

Cough, cold and allergy (hay fever) remedies are expected to register a decline in value sales. Value sales are now at more normal levels, as concerns about the COVID-19 virus have abated. In addition, Ecuador is grappling with rising crime rates and…

Cough, cold and allergy (hay fever) remedies are among the most popular consumer health items in the Dominican Republic and are experiencing further growth in 2023 despite higher unit prices resulting largely from persistent inflationary pressures…

At the end of 2022, there was an increase in the need to treat cold and flu symptoms. This was driven by the return of socialising following periods of social distancing, increased hand washing and the wearing of face masks throughout most of 2020…

In 2022, demand for cold, cough and allergy (have fever) remedies soared, as a result of the atypical increase in flu cases, as social distancing, handwashing protocols, and the use of face masks were totally lifted in 2022, facilitating the spread…

Cough, cold, and allergy (hay fever) remedies in Chile is experiencing remarkable growth for the second consecutive year in 2023, both in terms of volume and value. This upward trend can be attributed primarily to the return to normalcy following the…

In 2023, cough, cold and allergy (hay fever) remedies is set to maintain dynamic current value growth in Brazil. In this year, the conclusion of the Public Health Emergency of International Concern (PHEIC) for COVID-19, as declared by the World…

Seasonal flus have returned, as people mix together once again , post pandemic, and cough, cold and allergy (hay fever remedies) are expected to register moderate current value growth, though constant value growth will be minimal, as rising costs hit…

Retail sales of cough, cold and allergy (hay fever) remedies saw another year of healthy growth in constant value terms in 2023. With the resumption of pre-pandemic lifestyles, including a return to work, school and social activities, consumers…

The picture is fairly positive in 2023, with constant value sales expected to rise slightly and inflationary pressure easing. However, rising prices are still an issue and the overall economy is expected to register a slowdown in growth.

Consumer health shows variable recovery in 2023, with an ongoing return to the normalisation of sales patterns following the atypical period of the pandemic. Challenges, however, continue, such as the departure of President Castillo's government, in…

Consumer health declined in volume sales while retail value sales grew below inflation in 2023. This was mainly due to significant falls in the vitamins and dietary supplements and weight management and wellbeing categories while sports nutrition and…